Extracellular signal-related kinase 1/2 and p38 mitogen-activated protein kinase pathways serve opposite roles in neutrophil cytotoxicity

Archives of Surgery

Volumn 134, Issue 10, 1999, Pages 1074-1078

  Johnson, Jeffrey L ^a   Moore, Ernest E ^a   Patrick, David A ^a   Tamura, Douglas Y ^a   Zallen, Garret ^a   Elzi, David J ^a,b   Silliman, Christopher C ^a,b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b Bonfils Blood Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

AMINO ACID SEQUENCE; ARTICLE; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

CYTOTOXICITY, IMMUNOLOGIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PANCREATIC ELASTASE; SUPEROXIDES;

EID: 0032826769     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.134.10.1074     Document Type: Article

References (22)

1. Bogomolski-Yahatom V, Matzner Y. Disorders of neutrophil function. Blood Rev. 1995;9:183-190.
2. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75:257-277.
3. Cohen P. Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress. Adv Pharmacol. 1996;36:15-27.
4. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
5. Avdi NJ, Winston BW, Russel M, et al. Activation of MEKK by formyl-methionylleucyl-phenylalanine in human neutrophils. J Biol Chem. 1996;271:33598-33606.
6. Suchard SJ, Mansfield PJ, Boxer LA, Shayman JA. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide. J Immunol. 1997;158:4961-4967.
7. Nahas N, Molski TFP, Fernandez GA, Sha'afi RI. Tyrosine phosphorylation and activation of a new mitogen-activated protein kinase cascade in human neutrophils stimulated with various agonists. Biochem J. 1996;318:247-253.
8. Nick JA, Avdi NJ, Gerwins P, et al. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J Immunol. 1996;156:4867-4875.
9. Huang C-K, Zhan L, Ai Y, Jongstra J. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J Biol Chem. 1997;272:17-19.
10. Nick JA, Avdi NJ, Young SK, et al. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and fMLP. J Clin Invest. 1997;99:975-986.
11. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376.
12. Cuenda A, Rouse J, Doza YN, et al. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 1995;364:229-233.
13. Alessi DR, Cuenda P, Cohen P, et al. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
14. Coffer PJ, Geijsen N, M'Rabet L, et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J. 1998;329:121-130.
15. Krump E, Sangher JS, Pelech SL, et al. Chemotactic peptide N-formyl-Met-Leu-Phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J Biol Chem. 1997;272:937-944.
16. Kuroki M, O'Flaherty JT. Differential effects of a mitogen-activated protein kinase inhibitor on human neutrophil responses to Chemotactic factors. Biochem Biophys Res Commun. 1997;232:474-477.
17. Zu Y-L, Qi J, Gilchrist A, et al. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or fMLP stimulation. J Immunol. 1998;160:1982-1989.
18. Brumell JH, Chan CK, Butler J, et al. Regulation of Src homology 2-containing tyrosine phosphatase 1 during activation of human neutrophils. J Biol Chem. 1997; 272:875-882.
19. Brondello JM, Brunet A, Pouyssegur J, McKenzie FR. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44 MAPK cascade. J Biol Chem. 1997;272:1368-1376.
20. Tamura DY, Moore EE, Johnson JL, et al. p38 MAPK inhibition attenuates ICAM-1 upregulation in human microvascular endothelial cells. Surgery. 1998;124:403-407.
21. Partrick DA, Moore FA, Moore EE, et al. Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horizons. 1996;4:194-210.
22. Barnett C, Moore EE, Partrick DA, et al. ICAM:CD18 interaction mediates neutrophil cytotoxicity through protease release. Am J Physiol. 1998;274:C1634-C1644.